Developing a new drug is a very complex process and only one in a hundred candidates make it from the bench to the market.

Partnering with a specialized Contract Development and Manufacturing Organization (CDMO) can have many advantages especially for complex API like peptides or oligonucleotides.

This lecture discusses the key benefits of such a collaboration and the trends and innovation in the market that aim at better serving the needs of the customers.